The Situation
An innovative pharmaceutical company focused on chronic pain needed timely, strategic insight to guide commercial and brand strategy. With evolving market dynamics and emerging competitors, the client’s brand, CI, and market access teams required targeted intelligence to inform decision-making across three key indications.
The Solution
Sedulo launched a global monitoring program designed to keep the client ahead of competitor activity and aligned with shifting market conditions. The program was tailored to provide relevant updates and function-specific insights.
Real-Time Email Alerts: Delivered timely updates on competitor and market activity, contextualized with relevant strategic implications.
Ongoing Primary Intelligence: Conducted deep-dive analyses into clinical and commercial strategies across three pain-related therapeutic areas.
Newsletters: Created concise, function-specific updates to keep cross-functional teams informed on critical developments.
Landscape Reports: Produced detailed competitive landscape analyses for each indication, with insight into market positioning and timelines.
Conference Intelligence: Delivered onsite intelligence from key conferences, including ASPN and AAN, covering sessions and stakeholder feedback.
The Success
The client gained a comprehensive view of the competitive landscape through validated insights delivered by Sedulo. As a result, the client:
- Gained clear visibility into trial timelines, enrollment progress, dosing strategies, and clinical data
- Developed a deeper understanding of competitor partnerships, regulatory filings, and launch strategies
- Built a clearer picture of commercial tactics, including sales force structure, promotional approaches, and current and anticipated pricing strategy
With Sedulo’s tailored intelligence aligned to internal functions, the client was able to anticipate changes, mitigate risks, and strategically position their portfolio across three critical pain indications.